1. FRI0190 Clinical outcomes from a nationwide non-medical switch from originator to biosimilar etanercept in patients with inflammatory arthritis after 5 months follow-up. results from the danbio registry. (15th June 2017) Authors: Glintborg, B; Sørensen, IJ; Loft, AG; Esbesen, J; Lindegaard, H; Jensen, DV; Danebod, K; Dieperink, S; Hendricks, O; Hansen, IMJ; Linauskas, A; Kristensen, S; Andersen, LS; Hossein, M; Nordin, H; Andersen, BL; Chrysidis, S; Raun, JL; Manilo, N; Grydehøj, J Journal: Annals of the rheumatic diseases Issue: Volume 76(2017)Supplement 2 Page Start: 553 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. No diagnostic utility of antibody patterns against Klebsiella pneumoniae capsular serotypes in patients with axial spondyloarthritis vs. patients with non-specific low back pain: a cross-sectional study. (4th July 2017) Authors: Hermansen, LT; Loft, AG; Christiansen, AA; Munk, HL; Gilbert, L; Jurik, AG; Arnbak, B; Manniche, C; Weber, U; Østergaard, M; Pedersen, SJ; Barington, T; Junker, P; Hørslev-Petersen, K; Hendricks, O Journal: Scandinavian journal of rheumatology Issue: Volume 46:Number 4(2017) Page Start: 296 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗